Global Parkinson’s Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Carbidopa-Levodopa, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), By Route of Administration (Oral, Subcutaneous, Transdermal, and Others), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare

RELEASE DATE Dec 2024
REPORT ID SI4618
PAGES 232
REPORT FORMAT PathSoft

Request Free Sample

Your personal details will remain secure and confidential - Privacy Policy

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies